Program

Thursday, June 14th

8:30 - Registration

8:55 - Welcome Address
Dr Marvin Edeas, President of the French Society of Antioxidants, Paris, France

Session 1: Overview on Obesity

Chairmen: Dr P. Tounian & Dr G. Varela-Moreiras

9:00 - Controlling obesity in 2007: what should be changed and who is concerned?
What are the current strategies to prevent and treat obesity? (Increase of energy expenditure, decrease of energy intake, current used drugs…)
Pr Gregorio Varela-Moreiras, San Pablo CEU University, Madrid, Spain

9:30 - Antipsychotic-induced obesity: how can side effects be avoided?
Dr Renaud de Beaurepaire, Laboratory of Psychopharmacology Hospital Centre Paul Guiraud, Villejuif, France

10:00 - Latest advances on the Central Nervous System control of food intake and its involvements in obesity
What are the different pathways involved?
Can we modulate them?
How can we target them for prevention or treatment of obesity?
Dr Bernard Schmitt, CERN-CHBS, Lorient, France

10:30 - Break and poster session

Session 2: Nobody is equal:
From personalized obesity to personalized prevention or treatment

Chairmen: Pr K. Clément & Pr G. Shepherd

11:00 - Focus on childhood obesity
What are the respective parts of hereditary and environmental factors that lead to childhood obesity?
What are the strategies to prevent and treat obesity in children?
Pr. Patrick Tounian, Hôpital Armand-Trousseau, UMRS Inserm U872 Nutriomique, Paris, France

11:30 - Latest clinical developments on Pinnothin
Dr Louise Mennen, Lipid Nutrition, Loders Croklaan, Wormerveer, Netherlands

12:00 - Gender-specific aspects of obesity and related diseases
What are the differences in the impact of obesity on health between male and female?
Can we adapt prevention or treatments strategies in function of the gender?
Pr Vera Regitz-Zagrosek, Center for Cardiovascular Research Charité Campus Mitte, Berlin, Germany

12:30 - Lunch

14:00 - Obesity, genetics and prediposition
Are we all different in front of weight gain and obesity-related diseases?
Is Nutrigenomics the new way to personalized nutrition?
Pr Karine Clément, INSERM U755 Nutriomique, Hôtel-Dieu, Paris, France Perspectives in the field of obesity

14:30 - Focus on Infectobesity: how do pathogens cause obesity?
Dr Nikhil V. Dhurandhar, Pennington Biomedical Research Center Louisiana State University System, Baton Rouge, Louisiana, USA

15:00 - Flavour system in the Human brain: what are the perspectives for aromas and flavours in the prevention of obesity?
What are the connections between the flavour system and the eating behaviour?
In which way can this concept lead to a personalized diet?
What are the perspectives for Obesity prevention?
Dr Gordon Shepherd, Department of Neurobiology, Yale University School of Medicine, USA

15:30 - Break and poster session

16:00 - Short oral communications session 1, 2

16:00 - Calorie restriction, adiposity and metabolic health in humans
Dr Luigi Fontana, Washington University School of Medicine USA & Italian National Institute of Health, Italy

16:10 - Physiological genomic approach to assess the anti-obesity potential of a novel Calcium/Potassium salt of (-)-hydroxycitric acid
Dr Debasis Bagchi, Creighton University Medical Center, Omaha, Nebraska, USA

16:20 - The connection between obesity, breast-feeding and obstructive sleep Apnea
Dr Ahmed Heshmat, Calvert Memorial Hospital, Maryland, USA

16:30 - Genetic factors involved in energy balance control and feeding states change the olfactory sensitivity
Dr Pascaline Aimé, Laboratoire de Neurosciences sensorielles, Comportement, Cognition CNRS, université Claude Bernard Lyon, France

16:40 - Efficacy of slimteq1 in weight management in human volunters: a pilot study
Dr Anita Myatt, Laboratory of Nutrition and Nutritional Biochemistry, Yaounde, Cameroon

16:50 - Fat reducing activity of Slimaluma - Results of a study on an adipocyte cell line
Dr M.A Akbarsha, School of Life Sciences, Bharathidasan University, India

Discussion: Personalized prevention or treatment: myth or reality?

17:30 - End of the day

19:30 - Gala Dinner

Friday June 15th

Session 3: New targets in the obesity field

Chairmen: Pr R. Burcelin & Dr Y. Shi & Dr M Edeas

9:00 - The cells from the stroma-vascular fraction of adipose tissue: potential new targets to fight and prevent obesity?
Role of the vasculature and the stroma progenitor cells in the growth of the adipose tissue.
Characterization of the macrophages and lymphocytes present in the adipose tissue and interactions with adipocytes and endothelial cells.
Dr Anne Bouloumie, Inserm UPS U586, Institut Louis Bugnard University Paul Sabatier, Toulouse, France

9:30 - Obesity and mitochondrial dysfunction: how can we target the mitochondria?
Through which mechanisms can mitochondrial dysfunction lead to obesity?
Can the mitochondrial function be restored?
Mitochondria, thermogenesis and obesity: what are the perspectives for obesity prevention and treatment?
Pr Patrick Ritz, INSERM U694, Angers, France

10:00 - How can we target the adipocytes and mitochondria:
Film projection : Amphiphilic molecules to cross cell membranes, and reach the mitochondria
Dr Vicente Micol, Centro de Biologia molecular y celular, Alicante, Spain

10:15 - Break and poster session

10:45 - Targeting the nutrient absorption: what’s new in 2007?
What are the new lipase inhibitors?
Is there a potential role for new lipid metabolism modulators?
Can the carbohydrate metabolism be targeted? In which way?
Dr Yuguang Shi, Hershey Medical Center, Penn State University, Hershey, Pennsylvania, USA

11:15 - Gut hormones and appetite: targeting natural satiety
Dr Gavin Bewick, Imperial College London, Hammersmith Campus, London, United Kingdom

11:45 - Aquaporins and glycerol transport: a promising new target against obesity?
Dr Amaia Rodríguez, Metabolic Research Laboratory Clínica Universitaria de Navarra, Pamplona, Spain

12:15 - New role for GLP-1 and GLP-1 analogues: how does this pathway lead to weight loss?
Pr Remy Burcelin, CNRS-UMR5018, Université Paul Sabatier, Toulouse, France

12:45 - Lunch

Session 4: Latest advances on natural ingredients:
Prevention and alternative therapeutics of obesity

14:00 - Potential role of Resveratrol in the prevention and fight against obesity: The SIRT1/PGC-1 axis
Ms Marie Lagouge, Institut de Genetique et de Biologie Moleculaire et Cellulaire CNRS / INSERM / ULP, Illkirch, France

14:30 - Short oral communications session

14:30 - Effects of a new potato extract on natural satiety response and weight management in humans
Dr Sheila Dana, Kemin Health, L.C., Des Moines, Iowa, USA

14:40 - Effects of the nature of certain dietary fatty acides on certain obesity parameters
Dr Pierre Weill, Valorex, Combourtillé, France

14:50 - Effects of nutritional antioxidants on oxidative stress in obesity-induced diabetes
Dr Marjolaine Roche, Laboratory of Biochemistry and Molecular Genetic University of Réunion, France

15:00 - Intraperitoneally injected C75 reduces food intake in rats independent of abdominal vagal afferents or induction of a conditioned taste aversion
Dr Abdelhak Mansouri, Physiology and Behaviour Group, Institute of Animal Sciences Schwerzenbach, Switzerland

15:10 - The use of a cissus quadrangularis/ irvingia gabonensis combination in weight management in human volunters: a pilot study
Dr Julius Oben, Laboratory of Nutrition and Nutritional Biochemistry, Yaounde, Cameroon

15:20 - Round Table:

Discussion and Conclusion:
Prevention and Therapies of Obesity in 2007

Where are we going?
Why have we failed in slowing down the worldwide obesity pandemic?
Who is responsible: the Agro-Food and Pharmaceutical companies, the politics or the life style?
In the presence of the Scientific Committee

15:50 - End of the conference